MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 290 filers reported holding MIRATI THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.39 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $1,973,000 | -18.3% | 29,390 | 0.0% | 0.01% | +9.1% |
| Q1 2022 | $2,416,000 | -38.2% | 29,390 | +10.2% | 0.01% | -26.7% |
| Q4 2021 | $3,911,000 | -63.5% | 26,662 | -56.0% | 0.02% | -65.9% |
| Q3 2021 | $10,719,000 | +12.5% | 60,592 | +2.7% | 0.04% | +7.3% |
| Q2 2021 | $9,526,000 | +39.0% | 58,973 | +47.4% | 0.04% | -2.4% |
| Q1 2021 | $6,852,000 | -37.6% | 40,000 | -20.0% | 0.04% | -37.3% |
| Q4 2020 | $10,982,000 | – | 50,000 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 3,135,966 | $136,602,679 | 87.83% |
| EcoR1 Capital, LLC | 5,748,399 | $250,400,260 | 8.45% |
| Boxer Capital, LLC | 3,201,440 | $139,454,726 | 7.42% |
| RTW INVESTMENTS, LP | 6,768,514 | $294,836,470 | 6.22% |
| Paradigm Biocapital Advisors LP | 1,668,116 | $72,663,133 | 4.93% |
| Avoro Capital Advisors LLC | 6,666,666 | $290,399,971 | 4.53% |
| Octagon Capital Advisors LP | 655,051 | $28,534,022 | 4.38% |
| Artal Group S.A. | 2,024,226 | $88,175 | 3.78% |
| Ally Bridge Group (NY) LLC | 70,283 | $3,061,527 | 3.59% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 216,000 | $9,404,640 | 3.17% |